Literature DB >> 25041879

Pancreatic fistulae after pancreatic resections for neuroendocrine tumours compared with resections for other lesions.

Jasper Jan Atema1, Anneke P J Jilesen, Olivier R C Busch, Thomas M van Gulik, Dirk J Gouma, Els J M Nieveen van Dijkum.   

Abstract

BACKGROUND: Resection for pancreatic neuroendocrine tumours (PNET) is suggested to be associated with an increased risk of a post-operative pancreatic fistula (POPF). The aim of this study was to describe morbidity after resections for PNET, focusing on POPF. Outcomes were compared with resections for other lesions.
METHODS: Patients undergoing an elective pancreatic resection during a 12-year period were retrospectively analysed. Morbidity was defined according to the International Study Group of Pancreatic Surgery (ISGPS) definitions.
RESULTS: Eighty-eight out of 832 patients (10.6%) underwent a resection for PNET. Atypical pancreatic resections (enucleation and central pancreatectomy) and distal pancreatectomies were more frequently performed for PNET. The POPF rate was 22.7% in patients operated for PNET compared with 17.2% in other patients (P = 0.200). In univariate analysis, body mass index (BMI), pancreatic duct diameter, somatostatin analogue administration, type of resection and type of pathology were associated with a POPF. In multivariate analysis, BMI, a pancreatic duct diameter <3 mm and central pancreatectomy remained independent risk factors [odds ratio (OR) 1.93, 95% confidence interval (CI) 1.22-3.07 and OR 3.04, 95% CI 1.05-8.82, respectively].
CONCLUSIONS: High rates of POPF were found in patients operated for PNET. However, this was mainly owing to the fact that atypical resections, known to be associated with a higher fistula rate, were performed more frequently in these patients.
© 2014 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2014        PMID: 25041879      PMCID: PMC4266439          DOI: 10.1111/hpb.12319

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  49 in total

1.  Pathological incidence of duodenopancreatic neuroendocrine tumors in the Netherlands: a Pathologisch Anatomisch Landelijk Geautomatiseerd Archief study.

Authors:  Patricia Kuiper; Hein W Verspaget; Henk-Jan van Slooten; Lucia Overbeek; Izak Biemond; Cornelis B Lamers
Journal:  Pancreas       Date:  2010-11       Impact factor: 3.327

Review 2.  Parenchyma-sparing resections for pancreatic neoplasms.

Authors:  Stefano Crippa; Letizia Boninsegna; Stefano Partelli; Massimo Falconi
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-10-29       Impact factor: 7.027

Review 3.  Internal pancreatic duct stent does not decrease pancreatic fistula rate after pancreatic resection: a meta-analysis.

Authors:  Yu Zhou; Quanbo Zhou; Zhihua Li; Rufu Chen
Journal:  Am J Surg       Date:  2013-02-20       Impact factor: 2.565

4.  Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients.

Authors:  C C Solorzano; J E Lee; P W Pisters; J N Vauthey; G D Ayers; M E Jean; R F Gagel; J A Ajani; R A Wolff; D B Evans
Journal:  Surgery       Date:  2001-12       Impact factor: 3.982

5.  Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients.

Authors:  Jan Franko; Wentao Feng; Linwah Yip; Elizabeth Genovese; A James Moser
Journal:  J Gastrointest Surg       Date:  2009-12-09       Impact factor: 3.452

6.  Central pancreatectomy revisited.

Authors:  Kevin K Roggin; Udo Rudloff; Leslie H Blumgart; Murray F Brennan
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

Review 7.  Emerging strategies to prevent the development of pancreatic fistula after distal pancreatectomy.

Authors:  Ramon E Jimenez; William G Hawkins
Journal:  Surgery       Date:  2012-07-03       Impact factor: 3.982

8.  Hepatic neuroendocrine metastases: does intervention alter outcomes?

Authors:  R S Chamberlain; D Canes; K T Brown; L Saltz; W Jarnagin; Y Fong; L H Blumgart
Journal:  J Am Coll Surg       Date:  2000-04       Impact factor: 6.113

9.  Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy.

Authors:  Sébastien Gaujoux; Alexandre Cortes; Anne Couvelard; Séverine Noullet; Laurent Clavel; Vinciane Rebours; Philippe Lévy; Alain Sauvanet; Philippe Ruszniewski; Jacques Belghiti
Journal:  Surgery       Date:  2010-07       Impact factor: 3.982

10.  Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors.

Authors:  Massimo Falconi; Alessandro Zerbi; Stefano Crippa; Gianpaolo Balzano; Letizia Boninsegna; Vanessa Capitanio; Claudio Bassi; Valerio Di Carlo; Paolo Pederzoli
Journal:  Ann Surg Oncol       Date:  2010-02-17       Impact factor: 5.344

View more
  9 in total

Review 1.  Surgical resection of pancreatic neuroendocrine neoplasm by minimally invasive surgery-the robotic approach?

Authors:  Roxanne Y A Teo; Brian K P Goh
Journal:  Gland Surg       Date:  2018-02

Review 2.  [Early endocrine neoplasia of the pancreas].

Authors:  V Fendrich; D K Bartsch
Journal:  Chirurg       Date:  2018-04       Impact factor: 0.955

3.  Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.

Authors:  Javier A Cienfuegos; Joseba Salguero; Jorge M Núñez-Córdoba; Miguel Ruiz-Canela; Alberto Benito; Sira Ocaña; Gabriel Zozaya; Pablo Martí-Cruchaga; Fernando Pardo; José Luis Hernández-Lizoáin; Fernando Rotellar
Journal:  Surg Endosc       Date:  2017-01-26       Impact factor: 4.584

4.  Enucleation of non-invasive tumors in the proximal pancreas: indications and outcomes compared with standard resections.

Authors:  Wen-Jie Lu; Hao-Lei Cai; Ma-Dong Ye; Yu-Lian Wu; Bin Xu
Journal:  J Zhejiang Univ Sci B       Date:  2017 Oct.       Impact factor: 3.066

5.  Robot-Assisted Middle Pancreatectomy for Elderly Patients: Our Initial Experience.

Authors:  Tian Zhang; Xinjing Wang; Zhen Huo; Chenlei Wen; Zhichong Wu; Jiabin Jin; Dongfeng Cheng; Hao Chen; Xiaxing Deng; Baiyong Shen; Chenghong Peng
Journal:  Med Sci Monit       Date:  2015-09-23

6.  Male gender and increased body mass index independently predicts clinically relevant morbidity after spleen-preserving distal pancreatectomy.

Authors:  Traian Dumitrascu; Mihai Eftimie; Andra Aiordachioae; Cezar Stroescu; Simona Dima; Mihnea Ionescu; Irinel Popescu
Journal:  World J Gastrointest Surg       Date:  2018-11-27

Review 7.  Risk factors and preventive strategies for post-operative pancreatic fistula after pancreatic surgery: a comprehensive review.

Authors:  Kjetil Søreide; Knut Jørgen Labori
Journal:  Scand J Gastroenterol       Date:  2016-05-23       Impact factor: 2.423

Review 8.  Postoperative Complications, In-Hospital Mortality and 5-Year Survival After Surgical Resection for Patients with a Pancreatic Neuroendocrine Tumor: A Systematic Review.

Authors:  Anneke P J Jilesen; Casper H J van Eijck; K H in't Hof; S van Dieren; Dirk J Gouma; Els J M Nieveen van Dijkum
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

9.  A single-center experience with pancreatic cystic neuroendocrine tumors.

Authors:  Ange Khalil; Jacques Ewald; Ugo Marchese; Aurélie Autret; Jonathan Garnier; Patricia Niccoli; Gilles Piana; Flora Poizat; Marc Giovannini; Jean-Robert Delpero; Olivier Turrini
Journal:  World J Surg Oncol       Date:  2020-08-15       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.